The present invention relates to an improved process for the preparation of Ripretinib, crystalline forms of Form-M, Form-S and Form-N of Ripretinib, process for the preparation of crystalline forms and novel intermediate compound which is useful for the preparation of Ripretinib.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.